An Association of Chitinase-3 Like-Protein-1 With Neuronal Deterioration in Multiple Sclerosis
ASN Neuro · 2023-01 · 15 (1)
DOI: 10.1177/17590914231198980 ↗Kurz gefasst
Fachartikel in der Zeitschrift ASN Neuro, online erschienen am 07.12.2023. Verfasst von Intakhar Ahmad und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Medicine, University of Bergen, Bergen, Norway. Hauptthemen laut MEDLINE: Multiple Sclerosis, Chitinase-3-Like Protein 1. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Elevated levels of Chitinase-3-like protein-1 (CHI3L1) in cerebrospinal fluid have previously been linked to inflammatory activity and disease progression in multiple sclerosis (MS) patients. This study aimed to investigate the presence of CHI3L1 in the brains of MS patients and in the cuprizone model in mice (CPZ), a model of toxic/metabolic demyelination and remyelination in different brain areas. In MS gray matter (GM), CHI3L1 was detected primarily in astrocytes and in a subset of pyramidal neurons. In neurons, CHI3L1 immunopositivity was associated with lipofuscin-like substance accumulation, a sign of cellular aging that can lead to cell death. The density of CHI3L1-positive neurons was found to be significantly higher in normal-appearing MS GM tissue compared to that of control subjects (p = .014). In MS white matter (WM), CHI3L1 was detected in astrocytes located within lesion areas, as well as in perivascular normal-appearing areas and in phagocytic cells from the initial phases of lesion development. In the CPZ model, the density of CHI3L1-positive cells was strongly associated with microglial activation in the WM and choroid plexus inflammation. Compared to controls, CHI3L1 immunopositivity in WM was increased from an early phase of CPZ exposure. In the GM, CHI3L1 immunopositivity increased later in the CPZ exposure phase, particularly in the deep GM region. These results indicate that CHI3L1 is associated with neuronal deterioration, pre-lesion pathology, along with inflammation in MS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Medicine, University of Bergen, Bergen, Norway.
- Norwegian Multiple Sclerosis Competence Centre, Department of Neurology, Haukeland University Hospital, Bergen, Norway.
- Norwegian MS-registry and biobank, Department of Neurology, Haukeland University Hospital, Bergen, Norway.
- Neuro-SysMed, Haukeland University Hospital, Bergen, Norway.
- Proteomics Unit at the University of Bergen (PROBE), Department of Biomedicine, University of Bergen, Bergen, Norway.
- Institute of Marine Research, IMR, Bergen, Norway.
ORCID-Profile: Intakhar Ahmad
Zitieren
APA
Ahmad, I., Wergeland, S., Oveland, E., & Bø, L. (2023). An Association of Chitinase-3 Like-Protein-1 With Neuronal Deterioration in Multiple Sclerosis. ASN Neuro, 15(1). https://doi.org/10.1177/17590914231198980
Vancouver
Ahmad I, Wergeland S, Oveland E, Bø L. An Association of Chitinase-3 Like-Protein-1 With Neuronal Deterioration in Multiple Sclerosis. ASN Neuro. 2023;15(1). doi:10.1177/17590914231198980
BibTeX
@article{Ahmad2023,
author = {Ahmad, Intakhar and Wergeland, Stig and Oveland, Eystein and Bø, Lars},
title = {An Association of Chitinase-3 Like-Protein-1 With Neuronal Deterioration in Multiple Sclerosis},
journal = {ASN Neuro},
year = {2023},
volume = {15},
number = {1},
doi = {10.1177/17590914231198980}
}
EUVIMED